TIS intellectual knowledge is in the area of growth factors, whilst it is a long shot (as there is probably lower hanging fruit to collect first) it would be interesting to see if they perform any research into benign prostate cancer/enlargement. I recall that TIS have mentioned the potential to develop treatments for breast/prostate cancer previously.. A simple one off treatment to prevent excessive prostate enlargement could be a very large market opportunity.
TIS Price at posting:
50.0¢ Sentiment: LT Buy Disclosure: Not Held
